Silverfin false false 31/12/2024 01/01/2024 31/12/2024 Dr Robert Mead 10/12/2018 Dr Zoe Mead 15/04/2022 22 December 2025 The principal activity of the Company during the financial year was the provision of gastroenterology and endoscopy services. 11719449 2024-12-31 11719449 bus:Director1 2024-12-31 11719449 bus:Director2 2024-12-31 11719449 2023-12-31 11719449 core:CurrentFinancialInstruments 2024-12-31 11719449 core:CurrentFinancialInstruments 2023-12-31 11719449 core:ShareCapital 2024-12-31 11719449 core:ShareCapital 2023-12-31 11719449 core:RetainedEarningsAccumulatedLosses 2024-12-31 11719449 core:RetainedEarningsAccumulatedLosses 2023-12-31 11719449 core:Vehicles 2023-12-31 11719449 core:OfficeEquipment 2023-12-31 11719449 core:ComputerEquipment 2023-12-31 11719449 core:Vehicles 2024-12-31 11719449 core:OfficeEquipment 2024-12-31 11719449 core:ComputerEquipment 2024-12-31 11719449 core:CurrentFinancialInstruments 9 2024-12-31 11719449 core:CurrentFinancialInstruments 9 2023-12-31 11719449 2024-01-01 2024-12-31 11719449 bus:FilletedAccounts 2024-01-01 2024-12-31 11719449 bus:SmallEntities 2024-01-01 2024-12-31 11719449 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 11719449 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11719449 bus:Director1 2024-01-01 2024-12-31 11719449 bus:Director2 2024-01-01 2024-12-31 11719449 core:Vehicles 2024-01-01 2024-12-31 11719449 core:OfficeEquipment core:TopRangeValue 2024-01-01 2024-12-31 11719449 core:ComputerEquipment core:TopRangeValue 2024-01-01 2024-12-31 11719449 2023-01-01 2023-12-31 11719449 core:OfficeEquipment 2024-01-01 2024-12-31 11719449 core:ComputerEquipment 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Company No: 11719449 (England and Wales)

HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LTD

Unaudited Financial Statements
For the financial year ended 31 December 2024
Pages for filing with the registrar

HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LTD

Unaudited Financial Statements

For the financial year ended 31 December 2024

Contents

HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LTD

STATEMENT OF FINANCIAL POSITION

As at 31 December 2024
HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 December 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 36,029 46,942
36,029 46,942
Current assets
Debtors 4 14,849 6,015
Cash at bank and in hand 371,764 353,181
386,613 359,196
Creditors: amounts falling due within one year 5 ( 41,371) ( 14,847)
Net current assets 345,242 344,349
Total assets less current liabilities 381,271 391,291
Provision for liabilities ( 9,007) 0
Net assets 372,264 391,291
Capital and reserves
Called-up share capital 100 100
Profit and loss account 372,164 391,191
Total shareholders' funds 372,264 391,291

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Hertfordshire and Bedfordshire Gastroenterology (HBG) Ltd (registered number: 11719449) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Dr Robert Mead
Director

22 December 2025

HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Hertfordshire and Bedfordshire Gastroenterology (HBG) Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1 The Atrium Phoenix Square, Wyncolls Road, Colchester, CO4 9AS, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Vehicles 25 % reducing balance
Office equipment 4 years straight line
Computer equipment 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Trade and other debtors

Short-term debtors are measured at transaction price, less any impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

Trade and other creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other parties, loans to related parties and investments in ordinary shares.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Statement of Financial Position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Vehicles Office equipment Computer equipment Total
£ £ £ £
Cost
At 01 January 2024 54,359 0 3,952 58,311
Additions 0 144 2,270 2,414
Disposals 0 0 ( 3,952) ( 3,952)
At 31 December 2024 54,359 144 2,270 56,773
Accumulated depreciation
At 01 January 2024 9,060 0 2,309 11,369
Charge for the financial year 11,325 30 1,233 12,588
Disposals 0 0 ( 3,213) ( 3,213)
At 31 December 2024 20,385 30 329 20,744
Net book value
At 31 December 2024 33,974 114 1,941 36,029
At 31 December 2023 45,299 0 1,643 46,942

4. Debtors

2024 2023
£ £
Trade debtors 12,431 6,015
Amounts owed by directors 381 0
Prepayments 1,909 0
S455 128 0
14,849 6,015

5. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to directors 0 39
Accruals 5,729 1,497
Taxation and social security 35,642 13,311
41,371 14,847

6. Related party transactions

Transactions with the entity's directors

At 1 January 2024 the Company owed the Directors £39.
During the year the Company made net payments of £420 on behalf of the directors.
As at 31 December 2024 the balance owed to the Company by the directors was £381.